Article
Molecular profiling in non-small cell lung cancer: a step toward personalized medicine.
Archives of pathology & laboratory medicine - 1 Apr 2013
Raparia Kirtee, Villa Celina, DeCamp Malcolm M, Patel Jyoti D, Mehta Minesh P
Abstract excerpt
CONTEXT: Lung carcinoma is the result of sequential accumulation of genetic and epigenetic changes. Lung adenocarcinoma is a heterogeneous disease with diverse somatic mutations, and several of them include the so-called driver mutations, which may serve as "druggable" therapeutic targets. Thus, development of personalized approaches for the treatment of non-small cell lung carcinoma (NSCLC) mandates that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
